The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Biosensis Pty Ltd
Adelaide, Australia
A
11-50 Employees
2006
Key takeaway
Biosensis is a life science company that specializes in providing innovative products, including quality peptides for antibody blocking experiments, which are relevant to the field of peptide therapeutics. With nearly 30 years of experience, they support researchers in neuroscience, particularly focusing on neurotrophins and neurotrophin receptors.
Highlighted product
Product
Quality peptides for antibody blocking experiments!
Myrio Tx
Melbourne, Australia
A
11-50 Employees
2009
Key takeaway
Myrio Therapeutics is focused on developing antibody-based therapies that target intracellular proteins, including those associated with cancer and viral infections. Their innovative Retained DisplayTM (ReD) technology enhances the discovery of therapeutic antibodies, positioning them at the forefront of biotherapeutic advancements.
Highlighted product
Core business
Homepage - Myrio Tx
RAGE Biotech
Melbourne, Australia
A
1-10 Employees
2020
Key takeaway
RAGE Biotech is developing innovative peptide therapeutics that inhibit pro-inflammatory signaling from activated RAGE, targeting difficult-to-treat inflammatory diseases. Their approach also includes cutting-edge RNA-targeting technologies to enhance therapeutic efficacy.
Highlighted product
Core business
Programs | RAGE Biotech Pty Ltd ABN 33 640 194 770
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
ENDOTHERAPEUTICS PTY. LIMITED
Sydney, Australia
A
11-50 Employees
1999
Key takeaway
Endotherapeutics is dedicated to improving healthcare through innovative medical technologies, highlighting their commitment to enhancing quality of life. With over 20 years of experience, they have developed a strong understanding of healthcare systems, positioning themselves as a leading company in the field.
Highlighted product
Product
Oncology - Endotherapeutics
Endotherapeutics Oncology Products.
Prorenata Biotech
Gold Coast City, Australia
A
1-10 Employees
2021
Key takeaway
Prorenata Biotech specializes in genetic medicine and lipid nanoparticles, focusing on developing innovative therapeutics to address unmet health conditions. Their expertise in CRISPR and commitment to accelerating gene-based therapeutics could be relevant for advancements in peptide therapeutics.
Highlighted product
Core business
Nanomedicine - LNPs & Genetic Medicine - Prorenata Biotech
We are experts in Lipid Nanoparticles and Gene Editing using CRISPR. We will ensure your molecule reaches its full potential!
Bioprocess
Sydney, Australia
A
- Employees
-
Key takeaway
The company is currently evolving its focus towards the generation of recombinant polypeptides, which aligns with the increasing interest in novel proteins stemming from advancements in genomics. This development process includes in-house steps from conceptualization to evaluation, often in collaboration with external partners.
Highlighted product
Core business
Company - Bioprocess
Paradigm Biopharmaceuticals
Melbourne, Australia
A
51-100 Employees
-
Key takeaway
Paradigm Biopharmaceuticals is dedicated to transforming underutilized molecules into effective treatments for conditions like osteoarthritis and MPS, addressing unmet medical needs. Their innovative approach and commitment to ethical standards position them as a key player in the development of novel therapeutics.
Highlighted product
Core business
Paradigm Biopharmaceuticals
Paradigm Biopharmaceuticals Ltd. is a late-stage drug development company working with world leaders in pharmaceutical product development to approach science from a completely different angle.
Anthrocell Pty Ltd
Sydney, Australia
A
11-50 Employees
2010
Key takeaway
Anthrocell Pty Ltd is an Australian biotechnology company focused on commercializing a human-cell-based expression system that enhances the production of biopharmaceuticals. Their innovative platform, the Anthrocell Expression System (ACX™), aims to improve the clinical effectiveness and reduce the costs of therapeutic drugs, aligning with their vision of intelligent and affordable medicine for the 21st century.
Highlighted product
Core business
AnthroCell – Fully Human Biopharmaceuticals
Antisense Therapeutics
Melbourne, Australia
A
1-10 Employees
2000
Key takeaway
Percheron Therapeutics Limited is a clinical-stage biotechnology company that develops novel therapies for rare diseases.
Highlighted product
Core business
Main Header – Antisense Therapeutics
CELL THERAPIES PTY LTD
Melbourne, Australia
A
11-50 Employees
2002
Key takeaway
Cell Therapies is a contract development and manufacturing organization (CDMO) that specializes in the manufacturing of advanced cell-based therapies, including cell and gene therapies. With over 20 years of experience and a GMP-compliant facility, they ensure the delivery of high-quality therapeutic products that meet global regulatory standards.
Highlighted product
Core business
Cell Therapies | GMP Manufacturing of cell and gene therapies
Groundbreaking cell and gene therapy manufacturing and commercialization cell therapies is an Australian-based, globally-active commercial contract developm ...
Technologies which have been searched by others and may be interesting for you:
The Peptide Therapeutics industry in Australia presents a unique landscape with several key considerations for those interested in exploring this field. Regulatory compliance is crucial, as the Therapeutic Goods Administration (TGA) governs the approval and use of peptide-based therapies, necessitating adherence to stringent guidelines. Understanding the challenges posed by research and development costs is essential, as peptide synthesis and formulation can be complex and resource-intensive. However, opportunities abound due to Australia’s strong biotechnology sector and collaboration among universities, research institutions, and industry players, fostering innovation and growth. The competitive landscape is characterized by both established companies and emerging biotech firms, each striving to develop novel peptide therapeutics. Global market relevance is significant, as peptides are increasingly recognized for their therapeutic potential in areas such as cancer, diabetes, and autoimmune diseases, aligning with international trends. Additionally, environmental concerns related to peptide production, including waste management and sustainability practices, are becoming increasingly relevant. Companies that prioritize environmentally friendly methods may find a competitive edge. Overall, thorough research into these factors will provide valuable insights for navigating the peptide therapeutics industry in Australia.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Australia |
| Amount of fitting manufacturers | 131 |
| Amount of suitable service providers | 99 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1999 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Peptide Therapeutics?
Start-Ups who are working in Peptide Therapeutics are RAGE Biotech, Prorenata Biotech
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Biotechnology, Other, Pharmaceuticals, Medical, Healthcare
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
